Cargando…
Morphine, Oxygen, Nitrates, and Mortality Reducing Pharmacological Treatment for Acute Coronary Syndrome: An Evidence-based Review
Since it was first reported in 1912, acute coronary syndrome (ACS) has become the leading cause of death in the Western world. Several improvements that have been made over the years in the pharmacological treatment of ACS have reduced the relative risk of death due to myocardial infarction from 35-...
Autor principal: | de Alencar Neto, José Nunes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866121/ https://www.ncbi.nlm.nih.gov/pubmed/29581926 http://dx.doi.org/10.7759/cureus.2114 |
Ejemplares similares
-
A Review of Adverse Outcomes Following Intravenous Morphine Usage for Pain Relief in Acute Coronary Syndrome
por: Chen, Annie, et al.
Publicado: (2018) -
Systemic Inflammatory Response Syndrome Predicts Mortality in Acute Coronary Syndrome without Congestive Heart Failure
por: Fosco, Matías José, et al.
Publicado: (2010) -
Nitrates as a Marker of Multiple Co-morbidities and Increased Mortality in Patients Undergoing Percutaneous Coronary Intervention (PCI)
por: Yager, Neil, et al.
Publicado: (2022) -
Kidney Disease as Risk of In-Hospital Mortality in Patients With Acute Coronary Syndrome
por: Lenci Marques, Gustavo, et al.
Publicado: (2021) -
Oral NAloxone to overcome the moRphine effect in acute COronary syndrome patients treated with TICagrelor — NARCOTIC trial
por: Niezgoda, Piotr, et al.
Publicado: (2022)